Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
210.00    3.00 (1.45%)
Bid:
208.00
Ask:
209.00
Spread: 1.00 (0.481%)
Market Cap: £559.68m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

7 Apr 2016 07:00

RNS Number : 4131U
Costain Group PLC
07 April 2016
 

Costain Group PLC("Costain" or "the Company")

The following notification is made in accordance with DTR 3.1.4R (1) (a).

 

Costain Group PLC announces the following grant of share awards to certain directors of the Company under the Share Deferral Plan and the Company's Long Term Incentive Plan as detailed in sections (A) and (B) below.

(A) Costain Group PLC 2014 Share Deferral Plan

 

On 06 April 2016, awards over ordinary shares of 50p each in the Company were made under the Costain Group PLC 2014 Share Deferral Plan (the "Share Deferral Plan").

 

The awards granted under the Share Deferral Plan are structured as options with a nil exercise price over a number of shares (the "Awards"). No consideration was paid for the grant of the Awards.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares Under the Awards

Andrew Wyllie

51,643

Anthony Bickerstaff

34,428

 

The Awards will become exercisable on or around the second anniversary of the date of grant subject to the Rules of the Share Deferral Plan and the continued employment of the participants. To the extent that all or any part of the Awards become exercisable, they will remain exercisable until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

 

(B) Costain Group PLC 2014 Long Term Incentive Plan

On 06 April 2016, awards under the Costain Group PLC 2014 Long Term Incentive Plan (the "LTIP") were made over ordinary shares of 50p each in the Company in the form of nil-cost options (the "Awards").

No consideration was paid for the grant of the Awards.

The vesting of the Awards is subject to the satisfaction of certain performance conditions. The Annual Report 2015 included proposed performance conditions. The performance conditions have now been finalised by the Remuneration Committee of the Company and are as follows: an EPS target of 91.7p (for 15% vesting) and 101.7p (for 100% vesting), with vesting on a straight-line basis between the two. 50% of the Awards will normally vest three years after grant, subject to the satisfaction of performance conditions over the three year financial period ending 31 December 2018, whilst the remaining 50% of the Awards will normally vest on the fifth anniversary of the date of grant (with no further performance conditions required). The Awards will remain exercisable from the date of vesting of each half of the Awards until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares subject to the Award

Andrew Wyllie

132,678

Anthony Bickerstaff

87,913

The Company was informed of the above transactions on 06 April 2016.

 

07 April 2016

Enquiries:

Costain Group PLC Tel: 01628 842444Tracey Wood

Company Secretary

 

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSEFIMFMSEDL
Date   Source Headline
29th May 202512:19 pmRNSHolding(s) in Company
28th May 20257:00 amRNSRefinancing of Bank and Bonding Facilities
27th May 20253:49 pmRNSAdditional Listing
22nd May 20251:19 pmRNSHolding(s) in Company
19th May 20253:16 pmRNSHolding(s) in Company
19th May 202511:32 amRNSHolding(s) in Company
15th May 20254:40 pmRNSResult of AGM
15th May 20257:00 amRNSAGM Trading Update
7th May 20255:16 pmRNSHolding(s) in Company
6th May 20256:05 pmRNSHolding(s) in Company
1st May 20252:35 pmRNSTotal Voting Rights
28th Apr 202512:32 pmRNSScrip Dividend Reference Price
25th Apr 20259:28 amRNSHolding(s) in Company
22nd Apr 20252:40 pmRNSHolding(s) in Company
9th Apr 20252:48 pmRNSDirector/PDMR Shareholding
8th Apr 202510:47 amRNSAnnual Financial Report
2nd Apr 20259:19 amRNSAdditional Listing
1st Apr 20251:34 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSCostain awarded Urenco framework agreement
11th Mar 20257:00 amRNSCostain FY 2024
10th Feb 202512:00 pmRNSInvestor Presentation via Investor Meet Company
27th Jan 20257:00 amRNSTrading Update with Strong Forward Work Position
2nd Jan 202511:13 amRNSBlock listing Interim Review
24th Dec 202410:19 amRNSSteve Mogford External Appointment
19th Dec 20247:00 amRNSSiemens and Costain JV wins HS2 Systems Contract
12th Dec 20242:22 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNSCostain Wins New HS2 Systems Contract
2nd Dec 20241:39 pmRNSTotal Voting Rights
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20249:41 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 202410:23 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.